Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 174-179

  Sordelli, Micaela S ^a   Beltrame, Jimena S ^a   Cella, Maximiliano ^a   Franchi, Ana M ^a   Ribeiro, Maria Laura ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Anandamide; Cyclooxygenase 2; Implantation; Nitric oxide synthase; Prostaglandin; Receptive uterus

Indexed keywords

ANANDAMIDE; CANNABINOID 2 RECEPTOR; CYCLOOXYGENASE 2; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; NIDATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84861349375     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.034     Document Type: Article

References (44)

1. Aisemberg, J., Vercelli, C.A., Billi, S., Ribeiro, M.L., Ogando, D., Meiss, R., McCann, S.M., Rettori, V., Franchi, A.M., 2007. Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption. Proc. Nat. Acad. Sci. U.S.A. 104, 7534-7539.
2. Bishay, P., Schmidt, H., Marian, C., Haussler, A., Wijnvoord, N., Ziebell, S., Metzner, J., Koch, M., Myrczek, T., Bechmann, I., Kuner, R., Costigan, M., Dehghani, F., Geisslinger, G., Tegeder, I., 2010. R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One 5, 1-15.
3. Biswas, S., Kabir, S.N., Pal, A.K., 1998. The role of nitric oxide in the process of implantation in rats. J. Reprod. Fertil. 114, 157-161.
4. Bonventre, J.V., Huang, Z., Taheri, M.R., O'Leary, E., Li, E., Moskowitz, M.A., Sapirstein, A., 1997. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390, 622-625.
5. Bradford, M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Bredt, D.S., Snyder, S.H., 1989. Nitric oxide mediates glutamate linked enhancement of cGMP levels in the cerebellum. Proc. Nat. Acad. Sci. U.S.A. 86, 9030-9033.
7. Campbell, W.B., Ojeda, S.R., 1987. Measurement of prostaglandins by radioimmunoassay. Methods Enzymol. 141, 323-341.
8. Cella, M., Aisemberg, J., Sordelli, M.S., Billi, S., Farina, M., Franchi, A.M., Ribeiro, M.L., 2006. Prostaglandins modulate nitric oxide synthase activity early in time in the uterus of estrogenized rat challenged with lipopolysaccharide. Eur. J. Pharmacol. 534, 218-226.
9. Cella, M., Leguizamn, G.F., Sordelli, M.S., Cervini, M., Guadagnoli, T., Ribeiro, M.L., Franchi, A.M., Farina, M.G., 2008. Dual effect of anandamide on rat placenta nitric oxide synthesis. Placenta 29, 699-707.
10. Coutts, A.A., Brewster, N., Ingram, T., Razdan, R.K., Pertwee, R.G., 2000. Comparison of novel cannabinoid partial agonists and SR141716Ai n the guinea-pig small intestine. Br. J. Pharmacol. 129, 645-652.
11. Demuth, D.G., Molleman, A., 2006. Cannabinoid signaling. Life Sci. 78, 549-563.
12. Furchgott, R.F., Zawadzki, J.V., 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
13. Guo, Y., Wang, H., Okamoto, Y., Ueda, N., Kingsley, P.J., Marnett, L.J., Schmid, H.H., Das, S.K., Dey, S.K., 2005. N-acylphosphatidylethanolamine- hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem. 280, 23429-23432.
14. Holt, S., Paylor, B., Boldrup, L., Alajakku, K., Vandevoorde, S., Sundström, A., Cocco, M.T., Onnis, V., Fowler, C.J., 2007. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. Eur. J. Pharmacol. 565, 26-36.
15. Howlett, A.C., Breivogel, C.S., Childers, S.R., Deadwyler, S.A., Hampson, R.E., Porrino, L.J., 2004. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47, 345-358.
16. Lahav, M., Davis, J.S., Rennert, H., 1989. Mechanism of the luteolytic action of prostaglandin F-2 alpha in the rat. J. Reprod. Fertil. 37, 233-240.
17. Lim, H., Paria, B.C., Das, S.K., Dinchuk, J.E., Langenbach, R., Trzaskos, J.M., Dey, S.K., 1997. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91, 197-208.
18. Lim, H., Song, H., Paria, B.C., Reese, J., Das, S.K., Dey, S.K., 2002. Molecules in blastocyst implantation: uterine and embryonic perspectives. Vitam. Horm. 64, 43-76.
19. Maccarrone, M., 2008. CB2 receptors in reproduction. Br. J. Pharmacol. 153, 189-198.
20. Maccarrone, M., Bisogno, T., Valensise, H., Lazzarin, N., Fezza, F., Maccarrone, M., Bisogno, T., Valensise, H., Lazzarin, N., Fezza, F., 2002. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol. Hum. Reprod. 8, 188-195.
21. Mechoulam, R., Fride, E., Di Marzo, V., 1998. Endocannabinoids. Eur. J. Pharmacol 359, 1-18.
22. Mitchell, M.D., Sato, T.A., Wang, A., Keelan, J.A., Ponnampalam, A.P., Glass, M., 2008. Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism. Am. J. Physiol. Endocrinol. Metab. 294, 352-356.
23. Navarrete, C.M., Fiebich, B.L., de Vinuesa, A.G., Hess, S., de Oliveira, A.C., et al., 2009. Opposite effects of anandamide and N-arachidonoyl dopamine in the regulation of prostaglandin E and 8-iso-PGF formation in primary glial cells. J. Neurochem. 109, 452-464.
24. Novaro, V., Rettori, V., González, E.T., Jawerbaum, A., Faletti, A., Canteros, G., Gimeno, M.A., 1996. Interaction between uterine PGE and PGF2 alpha production and the nitridergic system during embryonic implantation in the rat. Prostaglandins 51, 363-376.
25. Novaro, V., González, E., Jawerbaum, A., Rettori, V., Canteros, G., Gimeno, M.F., 1997. Nitric oxide synthase regulation during embryonic implantation. Reprod. Fertil. Dev. 9, 557-564.
26. Novaro, V., Colman-Lerner, A., Ortega, F.V., Jawerbaum, A., Paz, D., Candelario-Jalil, E., Caballero, F.J., Calzado, M.A., Muñoz, E., 2001. Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod. Fertil. Dev. 13, 411-420.
27. Paria, B.C., Deutsch, D.D., Dey, S.K., 1996. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol. Reprod. Dev. 45, 183-192.
28. Paria, B.C., Song, H., Wang, X., Schmid, P.C., Krebsbach, R.J., Schmid, H.H., Bonner, T.I., Zimmer, A., Dey, S.K., 2001. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem. 276, 20523-20528.
29. Portier, M., Rinaldi-Carmona, M., Pecceu, F., Combes, T., Poinot-Chazel, C., Calandra, B., Barth, F., le Fur, G., Casellas, P., 1999. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. 288, 582-589.
30. Ribeiro, M.L., Cella, M., Farina, M.G., Franchi, A.M., 2003. Crosstalk between nitric oxide synthase and cyclooxygenase metabolites in the estrogenized rat uterus. Prostaglandins Leukot. Essent. Fatty Acids 68, 285-290.
31. Ribeiro, M.L., Cella, M., Farina, M.G., Franchi, A.M., 2004. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus. Neuroimmunomodulation 11, 191-198.
32. Ribeiro, M.L., Vercelli, C.A., Sordelli, M.S., Farina, M.G., Cervini, M., Billi, S., Franchi, A.M., 2009. 17?-estradiol and progesterone regulate anandamide synthesis in the rat uterus. Reprod. Biomed. Online 18, 209-218.
33. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrié, P., Brelire, J.C., Le Fur, G., 1995. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56, 1941-1947.
34. Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., Portier, M., Shire, D., Brelire, J.C., Le Fur, G.L., 1998. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284, 644-650.
35. Schmid, P., Paria, B.C., Krebsbach, R.J., Schmid, H.H.O., Dey, S.K., 1997. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. U.S.A. 94, 4188-4192.
36. Shirasuna, K., Watanabe, S., Asahi, T., Wijayagunawardane, M.P., Sasahara, K., Jiang, C., Matsui, M., Sasaki, M., Shimizu, T., Davis, J.S., Miyamoto, A., 2008. Prostaglandin F2alpha increases endothelial nitric oxide synthase in the periphery of the bovine corpus luteum: the possible regulation of blood flow at an early stage of luteolysis. Reproduction 135, 527-539.
37. Sordelli, M.S., Beltrame, J.S., Burdet, J., Zotta, E., Pardo, R., Cella, M., Franchi, A.M., Ribeiro, M.L., 2011. The effect of anandamide on uterine nitric oxide synthase activity depends on the presence of the blastocyst. PLoS One 6 (e18368-e18368).
38. Stewart, C.L., Kaspar, P., Brunet, L.J., Bhatt, H., Gadi, I., Köntgen, F., Abbondanzo, S.J., 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359, 76-79.
39. Väisänen-Tommiska, M., Mikkola, T.S., Ylikorkala, O., 2005. Misoprostol induces cervical nitric oxide release in pregnant, but not in nonpregnant, women. Am. J. Obstet. Gynecol. 193, 790-796.
40. Van Dross, R.T., 2009. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes. Mol. Carcinog. 48, 724-732.
41. Vercelli, C.A., Aisemberg, J., Billi, S., Cervini, M., Ribeiro, M.L., Farina, M., Franchi, A.M., 2009. Anandamide regulates lipopolysaccharide-induced nitric oxide synthesis and tissue damage in the murine uterus. Reprod. Biomed. Online 18, 824-831.
42. Willoughby, K.A., Moore, S.F., Martin, B.R., Ellis, E.F., 1997. The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282, 243-247.
43. Woodward, D.F., Carling, R.W., Cornell, C.L., Fliri, H.G., Martos, J.L., Pettit, S.N., Liang, Y., Wang, J.W., 2008. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol. Ther. 120, 71-80.
44. Yallampalli, C., Garfield, R.E., Byam-Smith, M., 1993. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 133, 1899-1902.